![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KLHL20 |
Gene summary for KLHL20 |
![]() |
Gene information | Species | Human | Gene symbol | KLHL20 | Gene ID | 27252 |
Gene name | kelch like family member 20 | |
Gene Alias | KHLHX | |
Cytomap | 1q25.1 | |
Gene Type | protein-coding | GO ID | GO:0000209 | UniProtAcc | A0A024R940 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
27252 | KLHL20 | CCI_1 | Human | Cervix | CC | 9.74e-09 | 7.44e-01 | 0.528 |
27252 | KLHL20 | CCI_3 | Human | Cervix | CC | 1.33e-05 | 6.39e-01 | 0.516 |
27252 | KLHL20 | LZE4T | Human | Esophagus | ESCC | 2.71e-02 | 1.35e-01 | 0.0811 |
27252 | KLHL20 | LZE24T | Human | Esophagus | ESCC | 7.17e-05 | 1.48e-01 | 0.0596 |
27252 | KLHL20 | P2T-E | Human | Esophagus | ESCC | 1.64e-19 | 2.93e-01 | 0.1177 |
27252 | KLHL20 | P4T-E | Human | Esophagus | ESCC | 5.40e-11 | 2.42e-01 | 0.1323 |
27252 | KLHL20 | P5T-E | Human | Esophagus | ESCC | 1.13e-07 | 1.28e-01 | 0.1327 |
27252 | KLHL20 | P8T-E | Human | Esophagus | ESCC | 7.68e-11 | 2.20e-01 | 0.0889 |
27252 | KLHL20 | P9T-E | Human | Esophagus | ESCC | 3.52e-11 | 2.77e-01 | 0.1131 |
27252 | KLHL20 | P10T-E | Human | Esophagus | ESCC | 7.67e-14 | 2.96e-01 | 0.116 |
27252 | KLHL20 | P11T-E | Human | Esophagus | ESCC | 2.44e-07 | 2.71e-01 | 0.1426 |
27252 | KLHL20 | P12T-E | Human | Esophagus | ESCC | 5.60e-06 | 1.90e-01 | 0.1122 |
27252 | KLHL20 | P15T-E | Human | Esophagus | ESCC | 2.60e-13 | 2.15e-01 | 0.1149 |
27252 | KLHL20 | P16T-E | Human | Esophagus | ESCC | 1.55e-09 | 2.30e-01 | 0.1153 |
27252 | KLHL20 | P20T-E | Human | Esophagus | ESCC | 1.22e-09 | 2.59e-01 | 0.1124 |
27252 | KLHL20 | P21T-E | Human | Esophagus | ESCC | 4.82e-13 | 2.82e-01 | 0.1617 |
27252 | KLHL20 | P22T-E | Human | Esophagus | ESCC | 2.31e-18 | 2.43e-01 | 0.1236 |
27252 | KLHL20 | P23T-E | Human | Esophagus | ESCC | 9.45e-10 | 2.60e-01 | 0.108 |
27252 | KLHL20 | P26T-E | Human | Esophagus | ESCC | 6.62e-13 | 2.35e-01 | 0.1276 |
27252 | KLHL20 | P27T-E | Human | Esophagus | ESCC | 1.68e-07 | 1.64e-01 | 0.1055 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001049810 | Cervix | CC | proteasomal protein catabolic process | 111/2311 | 490/18723 | 8.98e-11 | 1.58e-08 | 111 |
GO:004316110 | Cervix | CC | proteasome-mediated ubiquitin-dependent protein catabolic process | 91/2311 | 412/18723 | 1.65e-08 | 1.25e-06 | 91 |
GO:00002097 | Cervix | CC | protein polyubiquitination | 58/2311 | 236/18723 | 1.57e-07 | 7.41e-06 | 58 |
GO:00068927 | Cervix | CC | post-Golgi vesicle-mediated transport | 28/2311 | 104/18723 | 4.31e-05 | 6.61e-04 | 28 |
GO:00481938 | Cervix | CC | Golgi vesicle transport | 58/2311 | 296/18723 | 2.24e-04 | 2.54e-03 | 58 |
GO:00164827 | Cervix | CC | cytosolic transport | 33/2311 | 168/18723 | 4.43e-03 | 2.70e-02 | 33 |
GO:0010498111 | Esophagus | ESCC | proteasomal protein catabolic process | 369/8552 | 490/18723 | 1.13e-41 | 1.80e-38 | 369 |
GO:0043161111 | Esophagus | ESCC | proteasome-mediated ubiquitin-dependent protein catabolic process | 312/8552 | 412/18723 | 3.53e-36 | 4.48e-33 | 312 |
GO:004819318 | Esophagus | ESCC | Golgi vesicle transport | 231/8552 | 296/18723 | 1.82e-30 | 9.63e-28 | 231 |
GO:000020917 | Esophagus | ESCC | protein polyubiquitination | 170/8552 | 236/18723 | 1.40e-16 | 1.09e-14 | 170 |
GO:001648210 | Esophagus | ESCC | cytosolic transport | 124/8552 | 168/18723 | 9.69e-14 | 4.69e-12 | 124 |
GO:000689215 | Esophagus | ESCC | post-Golgi vesicle-mediated transport | 82/8552 | 104/18723 | 4.00e-12 | 1.55e-10 | 82 |
GO:00354555 | Esophagus | ESCC | response to interferon-alpha | 17/8552 | 21/18723 | 1.03e-03 | 5.19e-03 | 17 |
GO:00068953 | Esophagus | ESCC | Golgi to endosome transport | 13/8552 | 17/18723 | 1.00e-02 | 3.42e-02 | 13 |
GO:00104988 | Lung | IAC | proteasomal protein catabolic process | 90/2061 | 490/18723 | 6.69e-07 | 3.89e-05 | 90 |
GO:00431618 | Lung | IAC | proteasome-mediated ubiquitin-dependent protein catabolic process | 78/2061 | 412/18723 | 1.10e-06 | 6.02e-05 | 78 |
GO:00002096 | Lung | IAC | protein polyubiquitination | 49/2061 | 236/18723 | 8.51e-06 | 2.89e-04 | 49 |
GO:00068926 | Lung | IAC | post-Golgi vesicle-mediated transport | 27/2061 | 104/18723 | 1.54e-05 | 4.49e-04 | 27 |
GO:00164826 | Lung | IAC | cytosolic transport | 37/2061 | 168/18723 | 2.74e-05 | 7.26e-04 | 37 |
GO:00068952 | Lung | IAC | Golgi to endosome transport | 7/2061 | 17/18723 | 1.39e-03 | 1.53e-02 | 7 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KLHL20 | SNV | Missense_Mutation | c.1105N>A | p.Ala369Thr | p.A369T | Q9Y2M5 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-91-6829-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
KLHL20 | SNV | Missense_Mutation | c.548N>T | p.Arg183Leu | p.R183L | Q9Y2M5 | protein_coding | tolerated(0.28) | benign(0.017) | TCGA-MP-A4TI-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
KLHL20 | SNV | Missense_Mutation | novel | c.313C>T | p.Arg105Cys | p.R105C | Q9Y2M5 | protein_coding | deleterious(0) | probably_damaging(0.91) | TCGA-21-1080-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
KLHL20 | SNV | Missense_Mutation | c.172N>T | p.Ile58Phe | p.I58F | Q9Y2M5 | protein_coding | deleterious(0.03) | benign(0.009) | TCGA-22-5485-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
KLHL20 | SNV | Missense_Mutation | novel | c.1761N>C | p.Met587Ile | p.M587I | Q9Y2M5 | protein_coding | deleterious(0) | possibly_damaging(0.863) | TCGA-33-A4WN-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
KLHL20 | SNV | Missense_Mutation | novel | c.1067N>T | p.Cys356Phe | p.C356F | Q9Y2M5 | protein_coding | deleterious(0) | possibly_damaging(0.806) | TCGA-39-5040-01 | Lung | lung squamous cell carcinoma | Male | <65 | III/IV | Chemotherapy | cisplatin | PD |
KLHL20 | SNV | Missense_Mutation | novel | c.1235N>C | p.Gly412Ala | p.G412A | Q9Y2M5 | protein_coding | tolerated(0.08) | benign(0.314) | TCGA-56-A5DR-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
KLHL20 | SNV | Missense_Mutation | novel | c.115N>A | p.Gln39Lys | p.Q39K | Q9Y2M5 | protein_coding | tolerated(0.92) | benign(0) | TCGA-66-2734-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
KLHL20 | SNV | Missense_Mutation | c.700G>T | p.Ala234Ser | p.A234S | Q9Y2M5 | protein_coding | tolerated(0.06) | possibly_damaging(0.888) | TCGA-66-2770-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
KLHL20 | SNV | Missense_Mutation | novel | c.838G>C | p.Asp280His | p.D280H | Q9Y2M5 | protein_coding | tolerated(0.33) | probably_damaging(0.986) | TCGA-77-7141-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |